The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
The American Journal of Physiology
(1899) · The American Naturalist · doi:10.1086/277182 · Cited by 5,654
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“The stroma is essential for tumor growth, invasion and neovascularization [12, 22, 96, 97].”
BackgroundBiologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
International Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
Kawai, T., & Akira, S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401850 · Cited by 1,810
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Blood Vessel Formation: What Is Its Molecular Basis?
Folkman, J., & D'Amore, P. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81810-3 · Cited by 1,215
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140
VEGF-Induced Adult Neovascularization: Recruitment, Retention, and Role of Accessory Cells
Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Yung, S., Chimenti, S., Landsman, L., Abramovitch, R., & Keshet, E. (2006) · Cell · doi:10.1016/j.cell.2005.10.036 · Cited by 1,126
Mechanisms and functional significance of tumour-induced dendritic-cell defects
Gabrilovich, D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1498 · Cited by 1,024
IL-1 is required for tumor invasiveness and angiogenesis
Voronov, E., Shouval, D. S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., Dinarello, C. A., & Apte, R. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437939100 · Cited by 1,023
Self-citationThe roles of IFNγ in protection against tumor development and cancer immunoediting
Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00038-7 · Cited by 899
Horai, R., Saijo, S., Tanioka, H., Nakae, S., Sudo, K., Okahara, A., Ikuse, T., Asano, M., & Iwakura, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.313 · Cited by 749
Inflammation and necrosis promote tumour growth
Vakkila, J., & Lotze, M. T. (2004) · Nature Reviews Immunology · doi:10.1038/nri1415 · Cited by 690
Jung, Y.-J., Isaacs, J. S., Lee, S., Trepel, J., & Neckers, L. (2003) · The FASEB Journal · doi:10.1096/fj.03-0329fje · Cited by 679
Inflammation as a Tumor Promoter in Cancer Induction
Philip, M., Rowley, D. A., & Schreiber, H. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.006 · Cited by 640
How Toll-like receptors signal: what we know and what we don’t know
O’Neill, L. A. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.012 · Cited by 613
Interleukin l and T Cell Activation
Mizel, S. B. (1982) · Immunological Reviews · doi:10.1111/j.1600-065x.1982.tb00411.x · Cited by 613
Horai, R., Asano, M., Sudo, K., Kanuka, H., Suzuki, M., Nishihara, M., Takahashi, M., & Iwakura, Y. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1463 · Cited by 611
Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression
Bunt, S. K., Sinha, P., Clements, V. K., Leips, J., & Ostrand-Rosenberg, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.284 · Cited by 539
Tumor necrosis factor or tumor promoting factor?
Balkwill, F. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00020-x · Cited by 520
Cytokines as communication signals between leukocytes and endothelial cells
Mantovani, A., & Dejana, E. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90270-3 · Cited by 517
Dumitriu, I. E., Baruah, P., Valentinis, B., Voll, R. E., Herrmann, M., Nawroth, P. P., Arnold, B., Bianchi, M. E., Manfredi, A. A., & Rovere-Querini, P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7506 · Cited by 503
Blocking IL-1 in systemic inflammation
Dinarello, C. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050640 · Cited by 494
At the Crossroads of Inflammation and Cancer
Clevers, H. (2004) · Cell · doi:10.1016/j.cell.2004.09.005 · Cited by 493
AUTOCRINE AND PARACRINE REGULATION BY CYTOKINES AND GROWTH FACTORS IN MELANOMA
Lázár-Molnár, E., Hegyesi, H., Tóth, S., & Falus, A. (2000) · Cytokine · doi:10.1006/cyto.1999.0614 · Cited by 416
Proteases in invasion: matrix metalloproteinases
Stetler-Stevenson, W. G., & Yu, A. E. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0365 · Cited by 411
Extension of the Life-Span of Human Endothelial Cells by an Interleukin-1αAntisense Oligomer
Maier, J. A. M., Voulalas, P., Roeder, D., & Maciag, T. (1990) · Science · doi:10.1126/science.2218499 · Cited by 397
Coussens, L. M., & Werb, Z. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.f23 · Cited by 384
Costimulatory regulation of T cell function
Chambers, C. A., & Allison, J. P. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80027-1 · Cited by 377
Interleukin 1 is a radioprotector.
Neta, R., Douches, S., & Oppenheim, J. J. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2483 · Cited by 371
Torisu, H., Ono, M., Kiryu, H., Furue, M., Ohmoto, Y., NAKAYAMA, J., Nishioka, Y., Sone, S., & Kuwano, M. (2000) · PubMed · Cited by 363
NF-κB in cancer: a marked target
Lin, A., & Karin, M. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00128-1 · Cited by 355
Tumour necrosis factor α: a potential target for the therapy of solid tumours
Szlosarek, P. W., & Balkwill, F. R. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01196-3 · Cited by 355
Miller, L. S., O'Connell, R. M., Gutierrez, M. A., Pietras, E. M., Shahangian, A., Gross, C. E., Thirumala, A., Cheung, A. L., Cheng, G., & Modlin, R. L. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.011 · Cited by 348
The precursor form of IL-1α is an intracrine proinflammatory activator of transcription
Werman, A., Werman-Venkert, R., White, R., Lee, J.-K., Werman, B., Krelin, Y., Voronov, E., Dinarello, C. A., & Apte, R. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308705101 · Cited by 346
Self-citationKupper, T. S., Chua, A. O., Flood, P., McGuire, J., & Gubler, U. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113090 · Cited by 343
IL-18 regulates IL-1 β-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1
Vidal-Vanaclocha, F., Fantuzzi, G., Mendoza, L., Fuentes, A. M., Anasagasti, M. J., Martín, J., Carrascal, T., Walsh, P., Reznikov, L. L., Kim, S.-H., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.734 · Cited by 338
Derangement of immune responses by myeloid suppressor cells
Serafini, P., De Santo, C., Marigo, I., Cingarlini, S., Dolcetti, L., Gallina, G., Zanovello, P., & Bronte, V. (2004) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0443-2 · Cited by 335
Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis
Hill, R., Song, Y., Cardiff, R. D., & Van Dyke, T. (2005) · Cell · doi:10.1016/j.cell.2005.09.030 · Cited by 324
Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene
Nicklin, M. J. H., Hughes, D. E., Barton, J. L., Ure, J. M., & Duff, G. W. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.303 · Cited by 317
Mantovani, A., Allavena, P., & Sica, A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.03.016 · Cited by 311
Suganuma, M., Okabe, S., Marino, M. W., Sakai, A., Sueoka, E., & Fujiki, H. (1999) · PubMed · Cited by 303
Knight, B., Yeoh, G. C. T., Husk, K. L., Ly, T., Abraham, L. J., Yu, C., Rhim, J. A., & Fausto, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1809 · Cited by 301
Immature myeloid cells and cancer-associated immune suppression
Kusmartsev, S., & Gabrilovich, D. I. (2002) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-002-0280-8 · Cited by 297
Song, X., Krelin, Y., Dvorkin, T., Bjorkdahl, O., Segal, S., Dinarello, C. A., Voronov, E., & Apte, R. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8200 · Cited by 290
Self-citationInterleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1.
Mochizuki, D. Y., Eisenman, J. R., Conlon, P. J., Larsen, A. D., & Tushinski, R. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5267 · Cited by 289
The role of interleukin 1 in growth and metastasis of human cancer xenografts.
Elaraj, D. M., Weinreich, D. M., Varghese, S., Puhlmann, M., Hewitt, S. M., Carroll, N. M., Feldman, E. D., Turner, E. M., & Alexander, H. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1603 · Cited by 288
Nakao, S., Kuwano, T., Tsutsumi-Miyahara, C., Ueda, S.-I., Kimura, Y. N., Hamano, S., Sonoda, K.-H., Saijo, Y., Nukiwa, T., Strieter, R. M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23298 · Cited by 286
Torisu, H., Ono, M., Kiryu, H., Furue, M., Ohmoto, Y., Nakayama, J., Nishioka, Y., Sone, S., & Kuwano, M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000115)85:2%3c182::aid-ijc6%3e3.0.co;2-m · Cited by 254
Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
Strieter, R. M., Polverini, P. J., Arenberg, D. A., Walz, A., Opdenakker, G., Van Damme, J., & Kunkel, S. L. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.5.752 · Cited by 250
Saijo, Y., Tanaka, M., Miki, M., Usui, K., Suzuki, T., Maemondo, M., Hong, X., Tazawa, R., Kikuchi, T., Matsushima, K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.469 · Cited by 249
Role of interleukin 1 in the activation of T lymphocytes.
Lichtman, A. H., Chin, J., Schmidt, J. A., & Abbas, A. K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9699 · Cited by 225
Weaver, C. T., Hawrylowicz, C. M., & Unanue, E. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.8181 · Cited by 214
Interleukin-1—a major pleiotropic cytokine in tumor–host interactions
Apte, R. N., & Voronov, E. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00014-7 · Cited by 212
Self-citationApte, R. N., Krelin, Y., Song, X., Dotan, S., Recih, E., Elkabets, M., Carmi, Y., Dvorkin, T., White, R. M., Gayvoronsky, L., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.010 · Cited by 211
Self-citationZAMBON, C., BASSO, D., NAVAGLIA, F., BELLUCO, C., FALDA, A., FOGAR, P., GRECO, E., GALLO, N., RUGGE, M., & DIMARIO, F. (2005) · Cytokine · doi:10.1016/j.cyto.2004.10.013 · Cited by 205
Interleukin 1 is an autocrine regulator of human endothelial cell growth.
Cozzolino, F., Torcia, M., Aldinucci, D., Ziche, M., Almerigogna, F., Bani, D., & Stern, D. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6487 · Cited by 198
Stylianou, E., & Saklatvala, J. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00081-8 · Cited by 185
The Interleukin 1 Receptor: Ligand Interactions and Signal Transduction
Auron, P. E. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00018-5 · Cited by 179
Autocrine growth of CD4+ T cells. Differential effects of IL-1 on helper and inflammatory T cells.
Greenbaum, L. A., Horowitz, J. B., Woods, A., Pasqualini, T., Reich, E. P., & Bottomly, K. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.5.1555 · Cited by 178
Self-citationTumors are unique organs defined by abnormal signaling and context
Radisky, D., Hagios, C., & Bissell, M. J. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0360 · Cited by 177
Differential Effects of IL-1α and IL-1β on Tumorigenicity Patterns and Invasiveness
Song, X., Voronov, E., Dvorkin, T., Fima, E., Cagnano, E., Benharroch, D., Shendler, Y., Bjorkdahl, O., Segal, S., Dinarello, C. A., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6448 · Cited by 169
Self-citationTumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathway
Arnott, C. H., Scott, K. A., Moore, R. J., Hewer, A., Phillips, D. H., Parker, P., Balkwill, F. R., & Owens, D. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205588 · Cited by 165
Shibuya, K., Robinson, D. S., Zonin, F., Hartley, S. B., Macatonia, S. E., Somoza, C., Hunter, C. A., MURPHY, K. M. M., & O’Garra, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1708 · Cited by 164
Pantschenko, A., Pushkar, I., Anderson, K., Wang, Y., Miller, L., Kurtzman, S., Barrows, G., & Kreutzer, D. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.2.269 · Cited by 162
Amit, S., & Ben‐Neriah, Y. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00096-2 · Cited by 160
At the Crossroads of Inflammation and Tumorigenesis
Cordon-Cardo, C., & Prives, C. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1367 · Cited by 160
Eriksson, U., Kurrer, M. O., Sonderegger, I., Iezzi, G., Tafuri, A., Hunziker, L., Suzuki, S., Bachmaier, K., Bingisser, R. M., Penninger, J. M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021788 · Cited by 158
von Stebut, E., Ehrchen, J. M., Belkaid, Y., Kostka, S. L., Mölle, K., Knop, J., Sunderkötter, C., & Udey, M. C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030159 · Cited by 158
Wessendorf, J., Garfinkel, S., Zhan, X., Brown, S., & Maciag, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80653-x · Cited by 154
Interleukin‐1β, but not interleukin‐1α, is required for T‐cell‐dependent antibody production
Nakae, S., Asano, M., Horai, R., & Iwakura, Y. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01337.x · Cited by 154
An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors.
Scott, K. A., Moore, R. J., Arnott, C. H., East, N., Thompson, R. G., Scallon, B. J., Shealy, D. J., & Balkwill, F. R. (2003) · PubMed · Cited by 154
Kumar, S., Millis, A. J. T., & Baglioni, C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4683 · Cited by 150
Shibuya, K., Robinson, D. S., Zonin, F., Hartley, S. B., Macatonia, S. E., Somoza, C., Hunter, C. A., MURPHY, K. M. M., & O’Garra, A. (1998) · PubMed · Cited by 148
Vidal‐Vanaclocha, F., Amezaga, C. A. V.-D., Asumendi, A., Kaplanski, G., & Dinarello, C. A. (1994) · PubMed · Cited by 146
Maier, J. A. M., Statuto, M., & Ragnotti, G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1845 · Cited by 137
Su, S. B., Silver, P. B., Grajewski, R. S., Agarwal, R. K., Tang, J., Chan, C., & Caspi, R. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6303 · Cited by 136
Nakae, S., Asano, M., Horai, R., Sakaguchi, N., & Iwakura, Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.90 · Cited by 132
The role of IFN-γ in tumor transplantation immunity and inhibition of chemical carcinogenesis
Blankenstein, T. J. F., & Qin, Z. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00007-4 · Cited by 122
Vidal‐Vanaclocha, F., Alvarez, A., Asumendi, A., Urcelay, B., Tonino, P., & Dinarello, C. A. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.198 · Cited by 117
The N-terminal propiece of interleukin 1α is a transforming nuclear oncoprotein
Stevenson, F. T., Turck, J., Locksley, R. M., & Lovett, D. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.508 · Cited by 113
Filippi, C. M., Hugues, S., Cazareth, J., Julia, V., Glaichenhaus, N., & Ugolini, S. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021893 · Cited by 110
The interleukin-1 receptor complex and interleukin-1 signal transduction.
Martin, M. U., & Falk, W. (1997) · PubMed · Cited by 108
McArthur, J. G., & Raulet, D. H. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.5.1645 · Cited by 106
Sauder, D. N., Stanulis‐Praeger, B. M., & Gilchrest, B. A. (1988) · Archives of Dermatological Research · doi:10.1007/bf00417707 · Cited by 106
Okazaki, T., Ebihara, S., Asada, M., Kanda, A., Sasaki, H., & Yamaya, M. (2005) · International Immunology · doi:10.1093/intimm/dxh334 · Cited by 104
Carrascal, M. T., Mendoza, L., Valcárcel, M., Salado, C., Egilegor, E., Tellería, N., Vidal‐Vanaclocha, F., & Dinarello, C. A. (2003) · PubMed · Cited by 102
Intracellular Interleukin-1α Functionally Interacts with Histone Acetyltransferase Complexes
Buryskova, M., Pospíšek, M., Grothey, A., Simmet, T., & Burýšek, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306342200 · Cited by 98
Bar, D., Apte, R. N., Voronov, E., Dinarello, C. A., & Cohen, S. (2003) · The FASEB Journal · doi:10.1096/fj.03-0483fje · Cited by 98
Self-citationRoles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models
Iwakura, Y. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00021-7 · Cited by 96
Scherbarth, S., & Orr, F. W. (1997) · PubMed · Cited by 94
Scott, K. A., Arnott, C. H., Robinson, S. C., Moore, R. J., Thompson, R. G., Marshall, J. F., & Balkwill, F. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207915 · Cited by 94
Nakae, S., Naruse-Nakajima, C., Sudo, K., Horai, R., Asano, M., & Iwakura, Y. (2001) · International Immunology · doi:10.1093/intimm/13.12.1471 · Cited by 86
Interleukin-1 Family Expression in Human Breast Cancer: Interleukin-1 Receptor Antagonist
MILLER, L. J., Kurtzman, S. H., Anderson, K. L., Wang, Y., Stankus, M., Renna, M., Lindquist, R. R., Barrows, G. H., & Kreutzer, D. L. (2000) · Cancer Investigation · doi:10.3109/07357900009012171 · Cited by 85
Qin, Z., Kim, H. J., Hemme, J., & Blankenstein, T. J. F. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011887 · Cited by 79
Nozaki, S., Sledge, G. W., & Nakshatri, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3241 · Cited by 77
Estrov, Z., Kurzrock, R., Estey, E. H., Wetzler, M., Ferrajoli, A., Harris, D., Blake, M. E., Gutterman, J., & Talpaz, M. (1992) · Blood · doi:10.1182/blood.v79.8.1938.1938 · Cited by 76
IL-1 beta-deficient mice are resistant to induction of experimental SLE.
Voronov, E., Dayan, M., Zinger, H., Gayvoronsky, L., Lin, J.-P., Iwakura, Y., Apte, R. N., & Mozes, E. (2006) · PubMed · Cited by 75
Self-citationChirivi, R. G. S., Garofalo, A., Padura, I. M., Mantovani, A., & Giavazzi, R. (1993) · PubMed · Cited by 75
Palmieri, C., Roberts-Clark, D., Assadi-Sabet, A., Coope, R. C., O'Hare, M. J., Sunters, A., Hanby, A. M., Slade, M. J., Gomm, J., Lam, E. W. ‐., et al. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1770065 · Cited by 75
An SDF-1 Trap for Myeloid Cells Stimulates Angiogenesis
de Almodóvar, C. R., Luttun, A., & Carmeliet, P. (2006) · Cell · doi:10.1016/j.cell.2005.12.023 · Cited by 73
Douvdevani, A., Huleihel, M., Zöller, M., Segal, S., & Apte, R. N. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510526 · Cited by 73
Self-citationPollock, A. S., Turck, J., & Lovett, D. (2003) · The FASEB Journal · doi:10.1096/fj.02-0602com · Cited by 72
Murphy, J.-E., Morales, R. E., Scott, J. E., & Kupper, T. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5697 · Cited by 71
Wetzler, M., Kurzrock, R., Estrov, Z. E., Kantarjian, H. M., Gisslinger, H., Underbrink, M., & Talpaz, M. (1994) · Blood · doi:10.1182/blood.v84.9.3142.3142 · Cited by 70
Tomimatsu, S., Ichikura, T., & Mochizuki, H. (2001) · Cancer · doi:10.1002/1097-0142(20010401)91:7<1272::aid-cncr1128>3.0.co;2-z · Cited by 63
Kalli, K. R., Huntoon, C. J., Bell, M., & McKEAN, D. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3140 · Cited by 61
Regulation of Inhibitory Pathways of the Interleukin‐1 System
Mantovani, A., Muzio, M., Ghezzi, P., COLOTTA, C., & Introna, M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09573.x · Cited by 60
Interleukin 1-Dependent and -Independent Mouse Melanoma Metastases
Anasagasti, M. J., Olaso, E., Calvo, F., Mendoza, L., Martin, J. J., Bidaurrazaga, J., & Vidal‐Vanaclocha, F. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.9.645 · Cited by 58
Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RAS.
Beaupre, D. M., Talpaz, M., Marini, F. C., Cristiano, R. J., Roth, J. A., Estrov, Z., Albitar, M. X., Freedman, M. H., & Kurzrock, R. (1999) · PubMed · Cited by 54
Oelmann, E. M., Kraemer, A., Serve, H. L., Reufi, B., Oberberg, D., Patt, S., Herbst, H., Stein, H., Thiel, E., & Berdel, W. E. (1997) · International Journal of Cancer · Cited by 53
Voronov, E., Weinstein, Y., Benharroch, D., Cagnano, E., Ofir, R., Dobkin, M., White, R. M., Zöller, M., Barak, V., Segal, S., et al. (1999) · PubMed · Cited by 51
Self-citationDvorkin, T., Song, X., Argov, S., White, R. M., Zöller, M., Segal, S., Dinarello, C. A., Voronov, E., & Apte, R. N. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0905509 · Cited by 51
Self-citationHacham, M., Argov, S., White, R. M., Segal, S., & Apte, R. N. (2002) · PubMed · Cited by 51
Self-citationThe significant role of telomerase activity in human brain tumors
Nakatani, K., Yoshimi, N., Mori, H., Yoshimura, S.-I., Sakai, H., Shinoda, J., & Sakai, N. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970801)80:3<421::aid-cncr10>3.0.co;2-z · Cited by 50
Weinreich, D. M., Elaraj, D. M., Puhlmann, M., Hewitt, S. M., Carroll, N. M., Feldman, E. D., Turner, E. M., Spiess, P. J., & Alexander, H. R. (2003) · PubMed · Cited by 48
Hoo, W. S., Lundeen, K. A., Kohrumel, J. R., Pham, N.-L. L., Brostoff, S. W., Bartholomew, R. M., & Carlo, D. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7343 · Cited by 46
Gudkov, A. V. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.4.480 · Cited by 43
Polymorphism of IL-1 receptor antagonist gene: role in cancer.
Sehouli, J., Mustea, A., Könsgen, D., Katsares, I., & Lichtenegger, W. (2002) · PubMed · Cited by 43
Chirivi, R. G. S., Chiodoni, C., Musiani, P., Garofalo, A., Bernasconi, S., Colombo, M. P., & Giavazzi, R. (1996) · International Journal of Cancer · Cited by 40
Estrov, Z., Black, R., Sleath, P. R., Harris, D., Van, Q., LaPushin, R., Estey, E., & Talpaz, M. (1995) · Blood · doi:10.1182/blood.v86.12.4594.bloodjournal86124594 · Cited by 39
Chemical Carcinogens as Foreign Bodies and Some Pitfalls Regarding Cancer Immune Surveillance
Blankenstein, T. J. F., & Qin, Z. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)90006-6 · Cited by 38
Castelli, C., Sensi, M., Lupetti, R., Mortarini, R., Panceri, P., Anichini, A., & Parmiani, G. (1994) · PubMed · Cited by 37
Beasley, D., & Cooper, A. L. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.3.h901 · Cited by 36
Apte, R. N., Douvdevani, A., Zöller, M., White, R. M., Dvorkin, T., Shimoni, N., Fima, E., Hacham, M., Huleihel, M., Benharroch, D., et al. (1993) · Immunology Letters · doi:10.1016/0165-2478(93)90163-v · Cited by 35
Self-citationInterleukin-1 receptor antagonist mRNA expression and the progression of gastric carcinoma
Iizuka, N., Hazama, S., Hirose, K., Abe, T., Tokuda, N., Fukumoto, T., Tangoku, A., & Oka, M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00162-7 · Cited by 34
Li, X., Eckard, J., Shah, R., Malluck, C., & Frenkel, K. (2002) · PubMed · Cited by 32
MULTIFACTORIAL INDUCTION OF GENE EXPRESSION AND NUCLEAR LOCALIZATION OF MOUSE INTERLEUKIN 1α
Burýšek, L., & Houštěk, J. (1996) · Cytokine · doi:10.1006/cyto.1996.0062 · Cited by 31
Raf-induced transformation requires an interleukin 1 autocrine loop.
Vale, T., Ngo, T.-T. B., White, M. A., & Lipsky, P. E. (2001) · PubMed · Cited by 31
Self-citationGarfinkel, S., Haines, D. S., Brown, S., Wessendorf, J., Gillespie, D. H., & Maciag, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35776-4 · Cited by 30
Schirò, R., Longoni, D. V., Rossi, V., Maglia, O., Doni, A., Arsura, M., Carrara, G., Masera, G., Vannier, E. G., & Dinarello, C. A. (1994) · Blood · doi:10.1182/blood.v83.2.460.460 · Cited by 30
Zöller, M., Douvdevani, A., Segal, S., & Apte, R. N. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500321 · Cited by 29
Self-citationInterleukin‐1 produced by tumorigenic fibroblasts influences tumor rejection
Zöller, M., Doudevani, A., Segal, S., & Apte, R. N. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500320 · Cited by 26
Self-citationInterleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
McKenzie, R. C., Oran, A. E., Dinarello, C. A., & Sauder, D. N. (1996) · PubMed · Cited by 24
Stošić‐Grujičić, S., Basara, N., Milenković, P., & Dinarello, C. A. (1995) · Journal of Chemotherapy · doi:10.1179/joc.1995.7.1.67 · Cited by 23
Baharians, Z., & Schönthal, A. H. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199904)24:4<276::aid-mc5>3.0.co;2-# · Cited by 18
Rambaldi, A., Torcia, M. G., Dinarello, C. A., Barbui, T., & Cozzolino, F. (1993) · PubMed · Cited by 16
Vanhamme, L., Marshall, G. M., Schuh, A. C., et al. (1993) · PubMed · Cited by 11
Stošić‐Grujičić, S., Basara, N., & Dinarello, C. A. (1999) · Clinical & Laboratory Haematology · doi:10.1046/j.1365-2257.1999.00221.x · Cited by 7
Cited by
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945
“Early observations on augmentation of metastasis by IL-1 were subsequently extended to primary carcinogenesis in different organs (Apte et al., 2006; Salcedo et al., 2013).”
Ridker, P. M., MacFadyen, J. G., Thuren, T., Everett, B. M., Libby, P., Glynn, R. J., Ridker, P., Lorenzatti, A., Krum, H., Varigos, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32247-x · Cited by 1,344
Orjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K., & Campisi, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905299106 · Cited by 654
Metadata
- Authors
- Apte, R. N., Dotan, S., Elkabets, M., White, M. R., Reich, E., Carmi, Y., Song, X., Dvozkin, T., Krelin, Y., & Voronov, E.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2006-10-17
- Volume
- 25
- Issue
- 3
- Pages
- 387-408
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1999406693
- Cited by
- 593
- References
- 152
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.